A selective archive of company announcements, external industry coverage and milestones linked to original publications.
The 2025 announcement outlines the integration of Stone’s laboratory capabilities with Fibronostics’ work in non-invasive liver and metabolic diagnostics.
An industry publication covers Fibronostics’ acquisition and its potential role in expanding diagnostics and clinical research capabilities.
The company shared its branding transition and new headquarters in Santa Rosa Beach, Florida, in a public update.
The services and co-marketing partnership focused on making point-of-care and laboratory COVID-19 testing available to mass-screening settings.
The companies announced a collaboration around laboratory billing, collection workflows and reimbursement support.
The announcement describes an effort to make COVID-19 testing services more accessible to institutions and communities in Mississippi.
A company news item reports an agreement to support expanded COVID-19 testing access across Louisiana.
Following an on-site inspection, the company announced accreditation through the College of American Pathologists laboratory program.
The company reported a new in-network provider agreement, effective June 1, 2019, broadening its payer relationships.
No stories match those filters. Try another search or category.